Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07508189

Communication Intervention to Improve Influenza Vaccination Rates Among Elderly in Can Tho

This study evaluates the effectiveness of a multi-component community-based communication intervention to increase influenza vaccination rates among adults aged above 65 years in Can Tho City, Vietnam. Using a cluster randomised controlled trial design with stratified lottery randomisation, four study sites were selected from eight sites surveyed in a prior study: O Mon Ward and Truong Thanh Commune (intervention); Phuoc Thoi Ward and Truong Xuan Commune (control). The intervention includes community health education sessions, healthcare worker training, household visits, health communication banners, and Zalo-based vaccination reminders, delivered over 12 months (September 2025 to September 2026). Effectiveness is assessed by comparing pre- and post-intervention outcomes using Difference-in-Differences (DID) analysis.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

66 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Can Tho University of Medicine and Pharmacy

Can Tho, Can Tho City, 900000, Vietnam

About this study

This study employs a cluster randomised controlled trial (cluster RCT) design with a repeated cross-sectional approach. The unit of randomisation is the cluster (ward or commune).

RANDOMISATION:

From eight study sites surveyed in Objective 1 (four urban wards and four rural communes in Can Tho City), four sites were selected by stratified lottery randomisation. Within each stratum (urban and rural), one site was randomly assigned to the intervention group and one to the control group by lottery draw without investigator discretion:

  • Intervention: O Mon Ward (urban) and Truong Thanh Commune (rural)
  • Control: Phuoc Thoi Ward (urban) and Truong Xuan Commune (rural)

PARTICIPANTS:

All eligible permanent residents aged above 65 years at each study site were invited to participate. Data are collected at two independent cross-sectional time points:

  • T0: Baseline survey, August 2025 (n=952)
  • T1: Follow-up survey, September 2026 (n=approximately 1,200) Participants at T0 and T1 are not necessarily the same individuals; the design captures population-level changes within randomised clusters.

INTERVENTION (12 months: September 2025 to September 2026):

The 12-month duration encompasses both active implementation and the time required for knowledge, attitude, and behaviour change.

Phase 1 (September 2025, intensive activities):

  • Two community health education sessions per intervention site for adults aged >65 years and one cohabiting family member, with distribution of printed educational leaflets on influenza disease and vaccination. Attendance: O Mon Ward: Session 1 = 60 older adults + 40 family members, Session 2 = 57 older adults + 35 family members; Truong Thanh Commune: Session 1 = 60 + 38, Session 2 = 50 + 30.
  • One capacity-building workshop per site for healthcare workers and community health volunteers in vaccination counselling (O Mon Ward: n=30; Truong Thanh Commune: n=20).
  • Thirty household visits per site by trained community health volunteers to reinforce vaccination counselling.

Phase 2 (September 2025 to September 2026, ongoing):

  • Health communication banners displayed at health stations and community information centres throughout the intervention period.
  • Healthcare worker vaccination counselling integrated into all routine clinical contacts at intervention site health stations.
  • Zalo-based digital communication: weekly educational content and personalised vaccination reminders (December 2025 to January 2026, coinciding with peak influenza season in southern Vietnam).

CONTROL GROUP:

Received routine primary healthcare only, with no additional study-related activities.

ANALYSIS:

Effectiveness is measured using Difference-in-Differences (DID) regression, comparing changes between T0 and T1 across intervention and control clusters. Models use multivariable logistic regression (binary outcomes) and linear regression (continuous outcomes), adjusted for sociodemographic covariates. Intraclass correlation coefficients (ICC) were estimated for all outcomes and found to be negligible (ICC < 0.01), confirming the appropriateness of individual-level DID analysis.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Residents living in selected wards/communes in Can Tho City for at least 6 months.
  • Aged above 65 years.
  • Mentally and physically capable of participating in interviews and receiving communication interventions.
  • Agree to participate in the study and provide informed consent.

Exclusion criteria

  • Individuals with severe cognitive impairment or dementia.
  • Individuals with contraindications to influenza vaccination.
  • Planning to move out of the study area during the 12-month follow-up period.

Treatment and study plan

Multi-component Health Communication Package

Behavioral

A 12-month cluster-level communication intervention (Sep 2025-Sep 2026) delivered in two phases to all adults aged >65 years in intervention clusters:

Phase 1 (Sep 2025): (1) Two community health education sessions/site with influenza leaflets for older adults and family members; (2) HCW capacity-building workshop/site (O Mon: n=30; Truong Thanh: n=20); (3) Thirty household visits/site by community health volunteers.

Phase 2 (ongoing): (4) Health communication banners at health stations and community centres; (5) HCW point-of-care vaccination counselling at all clinical contacts; (6) Zalo-based weekly educational content and vaccination reminders (Dec 2025-Jan 2026).

Primary outcomes

  1. Influenza vaccination uptake in the preceding 12 months

    Time frame: Up to 12 months

    Proportion of participants who received influenza vaccination in the 12 months prior to survey, assessed by self-report. Baseline assessed August 2025; follow-up assessed September 2026. Intervention effect estimated using Difference-in- Differences (DID) regression comparing change between intervention and control clusters.

Secondary outcomes

  1. Influenza vaccination in calendar year 2025

    Time frame: Up to 12 months

    Proportion vaccinated against influenza during calendar year 2025, assessed by self-report at follow-up (September 2026).

  2. Influenza vaccination intention

    Time frame: Baseline and up to 12 months

    Proportion intending to receive influenza vaccination in the next 12 months, assessed by self-report at baseline (August 2025) and follow-up (September 2026).

  3. Healthcare worker vaccination counselling

    Time frame: Baseline and up to 12 months

    Proportion who received influenza vaccination counselling from a healthcare worker or community health volunteer in the preceding 12 months, assessed by self-report at baseline (August 2025) and follow-up (September 2026).

  4. Influenza knowledge score

    Time frame: Baseline and up to 12 months

    Total knowledge score (0-6) on influenza disease aetiology, transmission, complications, and vaccine characteristics. Higher scores indicate greater knowledge. Assessed at baseline (August 2025) and follow-up (September 2026). Analysed using linear regression DID.

  5. Vaccine hesitancy score (WHO-SAGE Vaccine Hesitancy Scale)

    Time frame: Baseline and up to 12 months

    Vaccine hesitancy measured using the WHO-SAGE Vaccine Hesitancy Scale (Vietnamese-adapted version). Higher scores indicate greater hesitancy. Assessed at baseline (August 2025) and follow-up (September 2026). Analysed using linear regression DID.

  6. Willingness to pay for influenza vaccination

    Time frame: Baseline and up to 12 months

    Proportion willing to pay out-of-pocket costs for influenza vaccination, assessed by self-report binary question at baseline (August 2025) and follow-up (September 2026).

Sponsors and collaborators

Lead sponsor

Can Tho University of Medicine and Pharmacy

Other

Collaborators

  • National Institute of Hygiene and Epidemiology, Vietnam

Registry information

Official study title

Effectiveness of Community-Based Communication Interventions to Improve Influenza Vaccination Rates Among the Elderly in Vietnam: A Cluster Randomized Controlled Trial

Acronym: CIVECT

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 2, 2026
Registry last updated
Jul 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.